Miyata Y, Chambraud B, Radanyi C, Leclerc J, Lebeau M C, Renoir J M, Shirai R, Catelli M G, Yahara I, Baulieu E E
Institut National de la Santé et de la Recherche Médicale Unité 33, 94276 Le Kremlin-Bicêtre Cédex, France.
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14500-5. doi: 10.1073/pnas.94.26.14500.
FKBP52 (HSP56, p59, HBI) is the 59-kDa immunosuppressant FK506-binding protein and has peptidyl prolyl isomerase as well as a chaperone-like activity in vitro. FKBP52 associates with the heat shock protein HSP90 and is included in the steroid hormone receptor complexes in vivo. FKBP52 possesses a well conserved phosphorylation site for casein kinase II (CK2) that was previously shown to be associated with HSP90. Here we examined whether FKBP52 is phosphorylated by CK2 both in vivo and in vitro. Recombinant rabbit FKBP52 was phosphorylated by purified CK2. We expressed and purified deletion mutants of FKBP52 to determine the site(s) phosphorylated by CK2. Thr-143 in the hinge I region was identified as the major phosphorylation site for CK2. A synthetic peptide corresponding to this region was phosphorylated by CK2, and the peptide competitively inhibited the phosphorylation of other substrates by CK2. The [32P]phosphate labeling of FKBP52-expressing cells revealed that the same site is also phosphorylated in vivo. FK506 binding to FKBP52 did not affect the phosphorylation by CK2 and, conversely, the FK506-binding activity of FKBP52 was not affected by the phosphorylation. Most importantly, CK2-phosphorylated FKBP52 did not bind to HSP90. These results indicate that CK2 phosphorylates FKBP52 both in vitro and in vivo and thus may regulate the protein composition of chaperone-containing complexes such as those of steroid receptors and certain protein kinases.
FKBP52(HSP56、p59、HBI)是一种59 kDa的免疫抑制剂FK506结合蛋白,在体外具有肽基脯氨酰异构酶以及类似伴侣蛋白的活性。FKBP52与热休克蛋白HSP90相关联,并在体内包含于类固醇激素受体复合物中。FKBP52拥有一个酪蛋白激酶II(CK2)的保守磷酸化位点,先前已证明该位点与HSP90相关。在此,我们研究了FKBP52在体内和体外是否被CK2磷酸化。重组兔FKBP52被纯化的CK2磷酸化。我们表达并纯化了FKBP52的缺失突变体,以确定被CK2磷酸化的位点。铰链I区域的苏氨酸-143被确定为CK2的主要磷酸化位点。对应于该区域的合成肽被CK2磷酸化,并且该肽竞争性抑制CK2对其他底物的磷酸化。表达FKBP52的细胞的[32P]磷酸盐标记显示,同一位点在体内也被磷酸化。FK506与FKBP52的结合不影响CK2的磷酸化,相反,FKBP52的FK506结合活性不受磷酸化的影响。最重要的是,CK2磷酸化的FKBP52不与HSP90结合。这些结果表明,CK2在体外和体内均使FKBP52磷酸化,因此可能调节含伴侣蛋白的复合物的蛋白质组成,如类固醇受体和某些蛋白激酶的复合物。